Evaluation of optical coherence tomography retinal thickness parameters for use in clinical trials for neovascular age-related macular degeneration.

PURPOSE To investigate the relationship between automated and manually derived measurements of central retinal thickness from optical coherence tomography (OCT) and to determine the relationship between the foveal center point (FCP) and the foveal central subfield (FCS) in neovascular age-related macular degeneration (AMD). METHODS Data were collected from 216 patients with newly diagnosed neovascular AMD, who underwent StratusOCT imaging at diagnosis. Raw StratusOCT images for each patient were analyzed with the publicly available custom software OCTOR, which allows accurate manual grading of OCT B-scans. Manually derived central retinal thickness measurements were compared with measurements obtained from automated StratusOCT analysis. Manually obtained measurements of FCP and FCS were also compared. RESULTS The mean (+/-SD) difference in thickness between automated and manually derived FCP thickness was 7.9 microm (+/-90.8), but the maximum difference was 455 microm. The limits of agreement (95% confidence interval), between automated and manually obtained FCP thicknesses, were -173.7 microm (lower limit) and 189.6 microm (upper limit), with a coefficient of determination (R(2)) of 0.49 (P < 0.001). In contrast, the R(2) for manually derived FCP and manually derived FCS thickness was 0.94 (P < 0.001), with a smaller mean (+/-SD) difference in thickness of 13.8 microm (+/-29.8). CONCLUSIONS Manual correction of errors in automated OCT segmentation may be necessary for accurate interpretation of anatomic outcomes for clinical trials of neovascular AMD. In addition, although measurement of FCS remains preferable for assessment of central retinal thickness, accurate measurement of FCP may represent an adequate alternative when FCS is unavailable.

[1]  Richard F Spaide,et al.  INTRAVITREAL BEVACIZUMAB TREATMENT OF CHOROIDAL NEOVASCULARIZATION SECONDARY TO AGE-RELATED MACULAR DEGENERATION , 2006, Retina.

[2]  L. Labree,et al.  Errors in retinal thickness measurements obtained by optical coherence tomography. , 2006, Ophthalmology.

[3]  William J Feuer,et al.  An optical coherence tomography-guided, variable dosing regimen with intravitreal ranibizumab (Lucentis) for neovascular age-related macular degeneration. , 2007, American journal of ophthalmology.

[4]  Adnan Tufail,et al.  Segmentation error in Stratus optical coherence tomography for neovascular age-related macular degeneration. , 2009, Investigative ophthalmology & visual science.

[5]  Lloyd Paul Aiello,et al.  Reproducibility of macular thickness and volume using Zeiss optical coherence tomography in patients with diabetic macular edema. , 2007, Ophthalmology.

[6]  Lloyd Paul Aiello A randomized trial comparing intravitreal triamcinolone acetonide and focal/grid photocoagulation for diabetic macular edema. , 2008, Ophthalmology.

[7]  Peter K Kaiser,et al.  Angiographic and optical coherence tomographic results of the MARINA study of ranibizumab in neovascular age-related macular degeneration. , 2007, Ophthalmology.

[8]  Ronald P Danis,et al.  Comparison of optical coherence tomography in diabetic macular edema, with and without reading center manual grading from a clinical trials perspective. , 2009, Investigative ophthalmology & visual science.

[9]  S. Binder,et al.  Optical coherence tomography: limits of the retinal-mapping program in age-related macular degeneration , 2008, British Journal of Ophthalmology.

[10]  G. Wollstein,et al.  Reproducibility of nerve fiber thickness, macular thickness, and optic nerve head measurements using StratusOCT. , 2004, Investigative ophthalmology & visual science.

[11]  J. Duker,et al.  Optical coherence tomography of age-related macular degeneration and choroidal neovascularization. , 1996, Ophthalmology.

[12]  A. Loewenstein,et al.  VARIABILITY AMONG RETINA SPECIALISTS IN EVALUATING FLUORESCEIN ANGIOGRAMS OF PATIENTS WITH NEOVASCULAR AGERELATED MACULAR DEGENERATION , 2007, Retina.

[13]  Paul G. Updike,et al.  Reproducibility of quantitative optical coherence tomography subanalysis in neovascular age-related macular degeneration. , 2007, Investigative ophthalmology & visual science.

[14]  E Reichel,et al.  Topography of diabetic macular edema with optical coherence tomography. , 1998, Ophthalmology.

[15]  F. Holz,et al.  Agreement among ophthalmologists in evaluating fluorescein angiograms in patients with neovascular age-related macular degeneration for photodynamic therapy eligibility (FLAP-study). , 2003, Ophthalmology.

[16]  C. Regillo,et al.  Anti-VEGF agents in the treatment of neovascular age-related macular degeneration: applying clinical trial results to the treatment of everyday patients. , 2007, American journal of ophthalmology.

[17]  U Chakravarthy,et al.  Relationships between clinical measures of visual function, fluorescein angiographic and optical coherence tomography features in patients with subfoveal choroidal neovascularisation , 2008, British Journal of Ophthalmology.

[18]  Peter K Kaiser,et al.  Optical coherence tomography 3: Automatic delineation of the outer neural retinal boundary and its influence on retinal thickness measurements. , 2004, Investigative ophthalmology & visual science.

[19]  C. Puliafito,et al.  Clinical applications of optical coherence tomography for the diagnosis and management of macular diseases. , 2004, Ophthalmology clinics of North America.

[20]  Mauricio E Pons,et al.  Redefining the limit of the outer retina in optical coherence tomography scans. , 2005, Ophthalmology.

[21]  Ziqiang Wu,et al.  Error correction and quantitative subanalysis of optical coherence tomography data using computer-assisted grading. , 2007, Investigative ophthalmology & visual science.

[22]  Maciej Wojtkowski,et al.  High-definition and 3-dimensional imaging of macular pathologies with high-speed ultrahigh-resolution optical coherence tomography. , 2006, Ophthalmology.

[23]  Ronald P Danis,et al.  Optical coherence tomography measurements and analysis methods in optical coherence tomography studies of diabetic macular edema. , 2008, Ophthalmology.

[24]  L. da Cruz,et al.  Repeatability of stratus optical coherence tomography measures in neovascular age-related macular degeneration. , 2008, Investigative ophthalmology & visual science.

[25]  Christopher Kai-shun Leung,et al.  Alignment artifacts in optical coherence tomography analyzed images. , 2007, Ophthalmology.

[26]  Jennifer I. Lim,et al.  Relationship between optical coherence tomography-measured central retinal thickness and visual acuity in diabetic macular edema. , 2007, Ophthalmology.

[27]  Eric A. Swanson,et al.  Quantitative Assessment of Macular Edema With Optical Coherence Tomography , 1995 .

[28]  J. Duker,et al.  A standardized method for reporting changes in macular thickening using optical coherence tomography. , 2005, Archives of ophthalmology.

[29]  Robin Ray,et al.  Evaluation of image artifact produced by optical coherence tomography of retinal pathology. , 2004, American journal of ophthalmology.

[30]  Robert J Zawadzki,et al.  Clinical application of rapid serial fourier-domain optical coherence tomography for macular imaging. , 2006, Ophthalmology.